BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2005
View Archived Issues
Preliminary phase IIb results on the effects of oral insulin spray in type 1 diabetes
Read More
MedImmune amends agreement with GSK for HPV vaccine
Read More
NM-100060 enters phase I study for onychomycosis
Read More
IND accepted for Norwood Abbey's autologous bone marrow transplant study
Read More
VP-025 for neuroinflammatory disorders enters phase I study
Read More
Pfizer submits lasofoxifene sNDA for treatment of vaginal atrophy
Read More
ViroLogic signs service agreement to support GSK HIV drug development
Read More
Premarket approval for BioGenex' InSite Her-2/neu Kit
Read More
Basilea enters global agreement with Cilag for ceftobiprole
Read More
HIV protease inhibitor PL-100 successfully completes viral crossresistance study
Read More
Enzon to discontinue pegamotecan development
Read More
FDA accepts BiDil NDA resubmission
Read More
Proxinium awarded orphan drug status for recurrent head and neck cancer
Read More
First phase III trial of an HIV vaccine shows no success in preventing infection
Read More
SR-147778: further evidence that CB1 antagonism may be effective for the treatment of alcoholism
Read More
T-type Ca2+ channel, therapeutic target for epilepsy and neuropathic pain, is blocked by KYS-05044
Read More
Telmisartan improves cerebral blood flow autoregulation in SHR
Read More
Neuroprotective effects of the PAF antagonist, LAU-0901, shown in a mouse transient ischemia model
Read More
Janssen publishes preclinical results for R-126638
Read More
Preclinical data on dual thromboxane synthase inhibitor and thromboxane receptor antagonist
Read More
AstraZeneca presents new P2X7 receptor antagonists
Read More
Phase II data on the effects of secretin in schizophrenia
Read More
Aurora kinase inhibitors developed at AstraZeneca
Read More
Novel antiviral agents in early development at BioCryst
Read More
BMS claims calcium-sensing receptor antagonists with utility in bone disorders
Read More
IKK inhibitors covered by Bristol-Myers Squibb patent
Read More
Patent discloses new antimitotic agents for cancer
Read More
Bosentan reported to improve survival of patients with primary pulmonary hypertension
Read More